Comparison of the effectiveness of conbercept and ranibizumab treatment for retinopathy of prematurity.

Yong ChengXuemei ZhuDandan LinghuJianhong Liang

Published in: Acta ophthalmologica (2020)

Conbercept and ranibizumab are effective for treating ROP. Compared with ranibizumab, conbercept resulted in less recurrence and longer treatment intervals.

Keyphrases

diabetic retinopathy
randomized controlled trial
age related macular degeneration
systematic review
combination therapy
free survival
clinical evaluation